Updates

Empresaria - Forecast eps of 14.3p for this year

April 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

2016 results, which include 12 months trading from US healthcare recruiter Pharmaceutical Strategies (8 months last year) as well as a couple of months from Rishworth (pilots and aviation personnel) and Consol Partners (IT), saw sales up 44% to £270m with pretax profit up 23% to £9.2m. Adjusted eps were up 14% to 11.3p.Net debt stands at £10.5m but clearly the deals have been transformational – and EMR is no longer the “tiny acorn” that we described it to be when we alighted on it in September ’14 at 47.25p. Overall, it has recorded 14 consecutive quarters of NFI growth (now £59m) and conversion of NFI into operating profit inched up from 16.3% to 16.6%. Segmentally, ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Blancco Technology

Warpaint -Notes from meeting with Finance Director

Empresaria - Focus turns to organic growth (September 2019)

Empresaria - Buys niche IT contractor (November 2016)

Empresaria (September 2016)

Empresaria - Buys aviation recruiter (August 2016)

Empresaria - Indian recruitment services side performing strongly (February 2016)

Empresaria - Buys high margin US healthcare recruiter (November 2015)

Empresaria - Will exceed market expectations (October 2015)

Empresaria - Forecast lifted to 8.8p for current year (April 2015)

Empresaria (February 2015)

Empresaria (January 2015)

Empresaria - Tiny acorn looks ready to grow (September 2014)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X